Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/09/08/2293151/0/en/GNT-Pharma-Announces-Approval-of-IND-Application-for-the-Phase-III-RODIN-Trial-of-Nelonemdaz-for-Acute-Ischemic-Stroke-Patients.html
https://scrip.pharmaintelligence.informa.com/SC144984/GNT-Eyes-Unmet-Need-As-Novel-Ischemic-Stroke-Therapy-Moves-To-Phase-III
https://www.businesswire.com/news/home/20201014005333/en/GNT-Pharma-Announces-Positive-Top-Line-Results-in-a-Phase-II-Study-of-Nelonemdaz-for-Acute-Ischemic-Stroke-Patients-Treated-With-Endovascular-Thrombectomy
https://www.afp.com/en/news/1314/gnt-pharma-announces-positive-top-line-results-phase-ii-study-nelonemdaz-acute-ischemic-stroke-patients-treated-endovascular-thrombectomy-202010140053331